I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Home > News and Publications > JHM Publications > Promise and Progress > Special Commemorative Issue: The Abeloff Era - Building Upon a Tradition of Excellence
Promise and Progress - Share of $120 Million Gift Goes to Cancer Genetics Research
Special Commemorative Issue: The Abeloff Era - Building Upon a Tradition of Excellence
Share of $120 Million Gift Goes to Cancer Genetics Research
Date: April 1, 2007
The Ludwig Center at Johns Hopkins Announced
A research team at the Johns Hopkins Kimmel Cancer Center is one of six in the nation to share in a $120 million gift from the Ludwig Fund, named for the late shipping tycoon Daniel K. Ludwig. Some $20 million will come to the newly-formed Ludwig Center at Johns Hopkins this year in addition to a lifetime annual commitment of $2 million.
The Ludwig Center at Johns Hopkins is based in the cancer genetics and therapeutics laboratory of Bert Vogelstein and Kenneth Kinzler. The Center is charged with further deciphering the genetic basis of human cancers so that novel approaches for the early detection and therapy of these diseases can be developed.
“We recognize that it takes more than a good idea to drive future discoveries in cancer research,” says Vogelstein. “It takes resources, and we’re grateful to the Ludwig Fund for its support.”
Vogelstein and Kinzler were among the pioneers in uncovering genetic mutations responsible for the onset and development of cancer. Most recently, with Ludwig Fund support, their team completed the first map of mutations found in colon and breast cancers.
“Johns Hopkins is revered as one of the outstanding institutions for cancer research in the world, and Drs. Vogelstein and Kinzler have been mighty contributors to this renown,” says Lloyd J. Old, M.D., chairman of the Ludwig Fund’s trustees. “Their work on the genetics of human cancer forms much of the basis for our current understanding and has identified a plethora of potential new therapeutic targets for cancer. The trustees are delighted that Drs. Vogelstein and Kinzler and their outstanding colleagues at Johns Hopkins will become an integral part of the collaborative network of Ludwig Centers and the Ludwig Institute for Cancer Research.”
Daniel Ludwig’s shipping empire was the largest in the United States during the 1960s and 70s, when its assets were reported at several billion. He died in 1992 after creating the Ludwig Institute, which has supported cancer research efforts with funding totaling $1.1 billion.
Kinzler and Vogelstein are consistently ranked by Science Watch magazine as two of the world’s most highly-cited scientists, with more than 100,000 citations in peer-reviewed journals, a common measure of scientific impact. Their work led to blood tests widely available for diagnosing hereditary forms of colon cancer, and their current research is focused on developing simple tests to detect early non-hereditary forms of cancer.
Along with Hopkins, the five other Ludwig Centers to share in the current award are the Dana-Farber Cancer Center/ Harvard, Memorial Sloan-Kettering Cancer Center, Massachusetts Institute of Technology, Stanford University, and the University of Chicago.